| P2093 | author name string | Lars F Westblade | |
| | Richard R Furman | |
| | Stephen G Jenkins | |
| | Audrey N Schuetz | |
| | Laura A Kirkman | |
| | Matthew S Simon | |
| | Alexis Dziedziech | |
| | Joseph E Visone | |
| P2860 | cites work | The Clinical Assessment, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: Clinical Practice Guidelines by the Infectious Diseases Society of America | Q22242935 |
| | Structural analysis of atovaquone-inhibited cytochrome bc1 complex reveals the molecular basis of antimalarial drug action | Q27690642 |
| | In vitro efficacy, resistance selection, and structural modeling studies implicate the malarial parasite apicoplast as the target of azithromycin | Q27861946 |
| | Ribosomal mutations in Streptococcus pneumoniae clinical isolates | Q34113722 |
| | Sequence and annotation of the apicoplast genome of the human pathogen Babesia microti | Q34287077 |
| | Sequence polymorphisms in the Pneumocystis carinii cytochrome b gene and their association with atovaquone prophylaxis failure | Q38331360 |
| | Diagnosis, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: A Review | Q38817827 |
| | Mutations in Plasmodium falciparum cytochrome b that are associated with atovaquone resistance are located at a putative drug-binding site | Q39474607 |
| | A global map of genetic diversity in Babesia microti reveals strong population structure and identifies variants associated with clinical relapse | Q40559129 |
| | Persistence of babesiosis for >2 years in a patient on rituximab for rheumatoid arthritis | Q40731843 |
| | Emergence of resistance to azithromycin-atovaquone in immunocompromised patients with Babesia microti infection | Q43202835 |
| | Persistent and relapsing babesiosis in immunocompromised patients | Q46817889 |
| | Characterization of cytochrome b from Toxoplasma gondii and Q(o) domain mutations as a mechanism of atovaquone-resistance | Q47862285 |
| | Persistent parasitemia after acute babesiosis | Q56777602 |
| | Atovaquone in the treatment of Babesia microti infections in hamsters | Q71466000 |
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | lymphocyte | Q715347 |
| | Babesia microti | Q7777786 |
| | azithromycin | Q165399 |
| | rituximab | Q412323 |
| P304 | page(s) | 1222-1225 | |
| P577 | publication date | 2017-10-01 | |
| P1433 | published in | Clinical Infectious Diseases | Q5133764 |
| P1476 | title | Clinical and Molecular Evidence of Atovaquone and Azithromycin Resistance in Relapsed Babesia microti Infection Associated With Rituximab and Chronic Lymphocytic Leukemia | |
| P478 | volume | 65 | |